Axion International Holdings, Inc. (OTCBB:AXIH) Let Go of the Dollar Levels

Axion International Holdings, Inc. (OTCBB:AXIH) slid more rapidly from its high position. On Tuesday, the ticker shed nearly nine percent, sliding to 93 cents on selling volumes of above $462,000. As we warned, the above-dollar positions were still vulnerable, as AXIH has not visited them in almost two years. The slide is easily explainable by the fact that the emailed promotion for the shares is growing stale, the latest message already 10 days old.

Now, AXIH can hope on a recovery based on a very positive Seeking Alpha profile, coming in just before markets reopen. AXIH now expects to reap the profits from an ongoing $42 million contract, which may mean much higher loyalty and interest for this stock. The only problem is that the partner for this contract remains hidden, and the whole message is too tentative. Until AXIH shows the results in its bottom line, and deals with its debt and losses, there is little ground for belief.

Investors’ forums remain relatively inactive, while normally news like this would be met with much higher interest, given that the company itself is capped at just $28 million, with only 31 million shares outstnding. At this rate, AXIH would certainly be more attractive, yet active buying does not happen without email messages recruiting new investors.

If you are looking for a similar situation, Provectus Pharmaceutical, Inc. (OTCMKTS:PVCT) just broke through the dollar again, on a steady climb. This ticker also has shown a propensity for deep cuts right after reaching a temporary peak.

Below that range, Titan Pharmaceuticals, Inc. (OTCBB:TTNP) also sometimes fights for the dollar level, still awaiting the event that will help it make the jump and finally engage investors enough so that they don’t depress the ticker by regular profit-taking. TTNP slid again a bit, reaching 82 cents. The shares were expected to make a jump, but enough negative news burned out most of the enthusiasm. Now, TTNP awaits November 19th for the results of an FDA meeting.

If you believe AXIH can still attack the dollar levels, it is best to realize that most of the latest run was due to a paid promotion and PR. The lack of noise may easily mean unraveling of the positions.

Decide well on your time frame and avoid investing unaffordable sums, so that AXIH does not catch you in one of the short-term daily or weekly corrections.